Dr. Hönle AG

EANS-News: Within the first nine months of the financial year the Hönle Group reports operating results of EUR 2.9 million and increases its forecasts for the year as a whole

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

quarterly report

Gräfeling, Munich (euro adhoc) - In the first nine months of financial years 2009/2010, the Hönle Group posted a 16.1 % increase in sales revenues to TEUR 39,023. Results of operations improved significantly compared to the previous year. Operating profit (EBITDA) climbed from TEUR -1,189 in the previous year to TEUR 3,801 in the first nine months of the current financial year. This increase in earning power is due to successful restructuring measures and the higher sales volume. Earnings before interest and taxes (EBIT) rose from TEUR -2,065 to TEUR 2,912 in the reporting period. Pre-tax earnings (EBT) climbed from TEUR -2,120 to TEUR 2,749 with an increase in consolidated income from the previous TEUR -1,655 to TEUR 1,801. Earnings per share rose from EUR -0.32 to EUR 0.32. The operating cash flow improved from TEUR -2.220 in the previous year to TEUR 2.975 in the first quarter of the current financial year.

Outlook: Within the course of financial year 2010 and to date, the global economy recovered sooner than was generally expected at the turn of the year. The Hönle Group benefits from this pick-up in demand. In both the systems and adhesives segments, Hönle assumes that the market recovery will be sustained. Hönle´s forecasts for the current financial year are therefore as follows: For the years as a whole, Hönle expects sales of more than EUR 52 million instead of the previously estimated EUR 47 to 50 million, and an operating result of over EUR 4 million instead of the previous EUR 3 to 4 million.

In order to account for future growth, Hönle decided in the past quarter to expand the rental space, in particular for production. Occupation of the new area at the Gräfelfing, Munich, site is planned for the end of 2011.

Since the acquisition of three companies or company groups, respectively, in 2008, the Hönle Group is the second largest systems supplier of industrial UV technology worldwide. Hence, Hönle has created a basis for achieving far higher sales and earnings levels than in the past. Hönle will work on realising this project in the coming years. One focus of its entrepreneurial activities will be on increasing the consumer goods proportion in the Hönle Group. To achieve this goal, Hönle will invest, among other things, in the development and sales segments of the Panacol Group and the service business. Moreover, Hönle may also purchase additional companies in order to increase consumer goods sales.

About Hönle: Dr. Hönle AG is a listed technology company with registered head office in Gräfelfing, near Munich. With a staff level of ca. 250 employees, the Hönle Group is one of the world´s leading systems suppliers in the UV technology segment. The equipment and systems are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and in the simulation of natural sunlight. The Company´s business activities focus also on the development and sale of industrial adhesives and compounds. The Group is represented by own companies and sales partners worldwide at 50 locations in more than 20 countries.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Peter Weinert
Tel.: +49 89 85608 173
E-Mail: peter.weinert@hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technology All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              Hannover / free trade
              München / free trade



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: